A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
Stopped Further recruitment into the study was ceased on 10th December 2009, not attributed to safety. All patients recruited in the study completed all study visits.
Conditions
Interventions
- BIOLOGICAL: Tanezumab
- DRUG: Placebo
Sponsor
Pfizer